131 related articles for article (PubMed ID: 22649693)
1. Transcription Factor DLX5 As a New Target for Promising Antitumor Agents.
Timakhov RA; Fedichev PO; Vinnik AA; Testa JR; Favorova OO
Acta Naturae; 2011 Jul; 3(3):47-51. PubMed ID: 22649693
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling.
Tan Y; Cheung M; Pei J; Menges CW; Godwin AK; Testa JR
Cancer Res; 2010 Nov; 70(22):9197-206. PubMed ID: 21045156
[TBL] [Abstract][Full Text] [Related]
3.
Zhang J; Wu J; Chen Y; Zhang W
Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
[TBL] [Abstract][Full Text] [Related]
4. DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.
Xu J; Testa JR
J Biol Chem; 2009 Jul; 284(31):20593-601. PubMed ID: 19497851
[TBL] [Abstract][Full Text] [Related]
5. A Computer - Aided Drug Designing for Pharmacological Inhibition of Mutant ALK for the Treatment of Non-small Cell Lung Cancer.
Sharda S; Khandelwal R; Adhikary R; Sharma D; Majhi M; Hussain T; Nayarisseri A; Singh SK
Curr Top Med Chem; 2019; 19(13):1129-1144. PubMed ID: 31109278
[TBL] [Abstract][Full Text] [Related]
6. Allelic reduction of Dlx5 and Dlx6 results in early follicular depletion: a new mouse model of primary ovarian insufficiency.
Bouhali K; Dipietromaria A; Fontaine A; Caburet S; Barbieri O; Bellessort B; Fellous M; Veitia RA; Levi G
Hum Mol Genet; 2011 Jul; 20(13):2642-50. PubMed ID: 21505076
[TBL] [Abstract][Full Text] [Related]
7. Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors.
Gómez-Ganau S; Castillo J; Cervantes A; de Julián-Ortiz JV; Gozalbes R
Curr Top Med Chem; 2020; 20(18):1628-1639. PubMed ID: 32493189
[TBL] [Abstract][Full Text] [Related]
8. Integrating Ligand and Target-Driven Based Virtual Screening Approaches With
Tutumlu G; Dogan B; Avsar T; Orhan MD; Calis S; Durdagi S
Front Chem; 2020; 8():167. PubMed ID: 32328476
[TBL] [Abstract][Full Text] [Related]
9. Activation of placenta-specific transcription factor distal-less homeobox 5 predicts clinical outcome in primary lung cancer patients.
Kato T; Sato N; Takano A; Miyamoto M; Nishimura H; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2008 Apr; 14(8):2363-70. PubMed ID: 18413826
[TBL] [Abstract][Full Text] [Related]
10.
Tan Y; Testa JR
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203994
[TBL] [Abstract][Full Text] [Related]
11. Msx1/Bmp4 genetic pathway regulates mammalian alveolar bone formation via induction of Dlx5 and Cbfa1.
Zhang Z; Song Y; Zhang X; Tang J; Chen J; Chen Y
Mech Dev; 2003 Dec; 120(12):1469-79. PubMed ID: 14654219
[TBL] [Abstract][Full Text] [Related]
12. DLX5 promotes osteosarcoma progression via activation of the NOTCH signaling pathway.
Zhang X; Bian H; Wei W; Wang Q; Chen J; Hei R; Chen C; Wu X; Yuan H; Gu J; Lu Y; Cai C; Zheng Q
Am J Cancer Res; 2021; 11(6):3354-3374. PubMed ID: 34249467
[TBL] [Abstract][Full Text] [Related]
13. Single crystal XRD, DFT investigations and molecular docking study of 2- ((1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino)naphthalene-1,4-dione as a potential anti- cancer lead molecule.
P R KR; Mary YS; Fernandez A; S AP; Mary YS; Thomas R
Comput Biol Chem; 2019 Feb; 78():153-164. PubMed ID: 30530296
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5.
Zhou J; Nie H; Liu P; Wang Z; Yao B; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):29-36. PubMed ID: 30657543
[TBL] [Abstract][Full Text] [Related]
15. EZH2/EHMT2 Histone Methyltransferases Inhibit the Transcription of DLX5 and Promote the Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia.
Zheng Z; Li L; Li G; Zhang Y; Dong C; Ren F; Chen W; Ma Y
Front Cell Dev Biol; 2021; 9():619795. PubMed ID: 34409024
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of BMP-2 activated genes in osteoblasts using gene expression microarray analysis: role of Dlx2 and Dlx5 transcription factors.
Harris SE; Guo D; Harris MA; Krishnaswamy A; Lichtler A
Front Biosci; 2003 Sep; 8():s1249-65. PubMed ID: 12957859
[TBL] [Abstract][Full Text] [Related]
17. Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers.
Zhou Y; Li X; Chen K; Ba Q; Zhang X; Li J; Wang J; Wang H; Liu H
Eur J Med Chem; 2021 Feb; 211():113000. PubMed ID: 33261896
[TBL] [Abstract][Full Text] [Related]
18. Insulin suppresses distal-less homeobox 5 expression through the up-regulation of microRNA-124 in 3T3-L1 cells.
Qadir AS; Woo KM; Ryoo HM; Baek JH
Exp Cell Res; 2013 Aug; 319(14):2125-34. PubMed ID: 23648570
[TBL] [Abstract][Full Text] [Related]
19. Distal-less homeobox 5 promotes the osteo-/dentinogenic differentiation potential of stem cells from apical papilla by activating histone demethylase KDM4B through a positive feedback mechanism.
Yang H; Fan J; Cao Y; Gao R; Fan Z
Exp Cell Res; 2019 Jan; 374(1):221-230. PubMed ID: 30503866
[TBL] [Abstract][Full Text] [Related]
20. Dlx5 and Dlx6 control uterine adenogenesis during post-natal maturation: possible consequences for endometriosis.
Bellessort B; Le Cardinal M; Bachelot A; Narboux-Nême N; Garagnani P; Pirazzini C; Barbieri O; Mastracci L; Jonchere V; Duvernois-Berthet E; Fontaine A; Alfama G; Levi G
Hum Mol Genet; 2016 Jan; 25(1):97-108. PubMed ID: 26512061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
